Literature DB >> 27875372

Cutaneous malignancies in HIV.

Aileen Y Chang1, Phil Doiron, Toby Maurer.   

Abstract

PURPOSE OF REVIEW: As patients with HIV infection are living longer with their disease, we have seen the evolution of skin cancer in this population. Cancer registries have not documented the incidence and prevalence of these cancers but we do have relevant data from cohorts. This article attempts to bring to light the extent to which skin cancer is an issue in HIV disease both domestically and internationally. RECENT
FINDINGS: Squamous cell cancer is increasing in incidence in the United States and elsewhere. The anatomic locations of skin cancer vary according to demographics, host factors, and environment. In this review, squamous cell cancer will be contrasted to the other skin cancers namely, melanoma, and basal cell cancers.
SUMMARY: As our HIV population ages, clinicians should be informed as to the relevant risk factors for development of skin cancer. With the increasing incidence of these cancers in the modern era of HIV, clinicians and researchers will be informed with regard to prevention and treatment strategies.

Entities:  

Mesh:

Year:  2017        PMID: 27875372     DOI: 10.1097/COH.0000000000000338

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  2 in total

Review 1.  cAMP-mediated regulation of melanocyte genomic instability: A melanoma-preventive strategy.

Authors:  Nathaniel C Holcomb; Robert-Marlo Bautista; Stuart G Jarrett; Katharine M Carter; Madeline Krentz Gober; John A D'Orazio
Journal:  Adv Protein Chem Struct Biol       Date:  2018-12-05       Impact factor: 3.507

Review 2.  Skin cancer biology and barriers to treatment: Recent applications of polymeric micro/nanostructures.

Authors:  Nazeer Hussain Khan; Maria Mir; Lei Qian; Mahnoor Baloch; Muhammad Farhan Ali Khan; Asim-Ur- Rehman; Ebenezeri Erasto Ngowi; Dong-Dong Wu; Xin-Ying Ji
Journal:  J Adv Res       Date:  2021-06-16       Impact factor: 10.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.